COMPANY PROFILE

LIfT BioSciences

Lift Biosciences is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

London, United KingdomFounded 2016Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About LIfT BioSciences

LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: London, United Kingdom
Employees: 22
Open positions: None listed
Dealroom signal: 81.8/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Research and Development, European Health Catapult (EIT Health), European Health Catapult 2018 (EIT Health), Clinical Trials, Biotech and Pharma, EIT Health, Hard Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Jul 2025	$13M	—	Disruptive Technologies Innovation Fund	↗
SERIES A✓Equity / VC	Sep 2024	$13M	$53M	Starbloom Capital · LifeSpan Vision Ventures · Jonathan Milner · Sijbrandij Foundation	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

LIfT BioSciences website traffic

Latest recorded traffic for LIfT BioSciences is 1.7K monthly website visits, up 0% over the last three months. LIfT BioSciences's team grew 0% over the past year.

Latest monthly visits1.7K 3-month web change0% 1-year team growth0%

Monthly website visitsOct 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OBOchre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally	Oxford, United Kingdom	Operational	62	$40M	$120M
ZHZio HealthPocket-sized biosensor technology for point-of-care molecular testing	London, United Kingdom	Operational
SBSixfold BioscienceAI-powered programmable RNA delivery system for therapeutics.	London, United Kingdom	Operational
LHLindus HealthAccelerates clinical trials for biotech and healthtech pioneers	London, United Kingdom	Operational
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational
ILiLoFAI and photonics platform for personalized drug discovery.	London, United Kingdom	Operational
PHPharmaforesight.aiDeveloped a powerful machine learning algorithm that can predict the probability of success of a trial, before it has even started	London, United Kingdom	Operational
SISmart ImmuneDevelops off-the-shelf allogeneic T-cell progenitor therapies to restore a fully functional immune system in patients with cancer and severe infections	Paris, France	Operational